TD Asset Management
TNYA icon

TD Asset Management’s Tenaya Therapeutics TNYA Stock Holding History

TD Asset Management’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-219,932
Closed -$713K – 1434
2023
Q4 		$713K Hold
219,932
– – ﹤0.01% 1246
2023
Q3 		$561K Buy
219,932
+109,966
+100% +$460K ﹤0.01% 1256
2023
Q2 		$646K Sell
109,966
-4,964
-4% -$28.9K ﹤0.01% 1217
2023
Q1 		$328K Hold
114,930
– – ﹤0.01% 1330
2022
Q4 		$231K Buy
114,930
+53,286
+86% +$130K ﹤0.01% 1378
2022
Q3 		$186K Hold
61,644
– – ﹤0.01% 1404
2022
Q2 		$347K Hold
61,644
– – ﹤0.01% 1340
2022
Q1 		$726K Buy
61,644
+26,366
+75% +$319K ﹤0.01% 1290
2021
Q4 		$669K Buy
35,278
+4,970
+16% +$108K ﹤0.01% 1349
2021
Q3 		$626K Buy
+30,308
New +$651K ﹤0.01% 1353

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TD Asset Management's TNYA Position: Q1 2024 in Review

TD Asset Management sold out of Tenaya Therapeutics (TNYA) in Q1 2024, closing a stake of 219,932 shares — an estimated $713K sold.

TD Asset Management first reported a position in TNYA in Q3 2021 and held it in 10 quarters. The position peaked at $726K in Q1 2022. 90 funds tracked by Wall St. Rank hold TNYA as of Q1 2024.

  • TD Asset Management reported no remaining Tenaya Therapeutics position as of Q1 2024 after selling out during the quarter.
  • TD Asset Management sold 219,932 Tenaya Therapeutics shares in Q1 2024, an estimated $713K.
  • TD Asset Management first reported a position in Tenaya Therapeutics in Q3 2021 and held it in 10 quarters.
  • TD Asset Management's Tenaya Therapeutics position peaked at $726K in Q1 2022.
  • 90 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2024.

Based on TD Asset Management's 13F filing for Q1 2024, filed 8 May 2024.